Treatment of Recalcitrant Pemphigus Vulgaris With the Tumor Necrosis Factor α Antagonist Etanercept

Article Type
Article
Changed
Thu, 12/15/2022 - 15:14
Display Headline
Treatment of Recalcitrant Pemphigus Vulgaris With the Tumor Necrosis Factor α Antagonist Etanercept
Author(s)
Berookhim B
Fischer HD
Weinberg JM

Article PDF
074040245.pdf
Author and Disclosure Information

Berookhim B, Fischer HD, Weinberg JM

Issue
Cutis - 74(4)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
245-247
Sections
Clinical Topics & News
Author(s)
Berookhim B
Fischer HD
Weinberg JM
Author(s)
Berookhim B
Fischer HD
Weinberg JM
Author and Disclosure Information

Berookhim B, Fischer HD, Weinberg JM

Author and Disclosure Information

Berookhim B, Fischer HD, Weinberg JM

Article PDF
074040245.pdf
Article PDF
074040245.pdf

Issue
Cutis - 74(4)
Issue
Cutis - 74(4)
Page Number
245-247
Page Number
245-247
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Treatment of Recalcitrant Pemphigus Vulgaris With the Tumor Necrosis Factor α Antagonist Etanercept
Display Headline
Treatment of Recalcitrant Pemphigus Vulgaris With the Tumor Necrosis Factor α Antagonist Etanercept
Sections
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Fischer HD